Considering Therapeutic Antibodies

Science  21 Jul 2006:
Vol. 313, Issue 5785, pp. 308-309
DOI: 10.1126/science.1130482

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Unexpected dangerous side effects of antibody-based therapies may be prevented with improved design of monoclonal antibodies and of clinical testing protocols.